Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy

NCT02366871 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Gynecologic Cancer
Venous Thromboembolism

Interventions

DRUG: Oral apixaban
DRUG: Subcutaneous enoxaparin

Sponsor

University of Colorado, Denver

Collaborators

[object Object]